Works matching IS 00071048 AND DT 2007 AND VI 138 AND IP 3


Results: 21
    1
    2
    3
    4

    Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.

    Published in:
    British Journal of Haematology, 2007, v. 138, n. 3, p. 330, doi. 10.1111/j.1365-2141.2007.06656.x
    By:
    • Kropff, Martin;
    • Bisping, Guido;
    • Schuck, Elke;
    • Liebisch, Peter;
    • Lang, Nicola;
    • Hentrich, Markus;
    • Dechow, Tobias;
    • Kröger, Nicolaus;
    • Salwender, Hans;
    • Metzner, Bernd;
    • Sezer, Orhan;
    • Engelhardt, Monika;
    • Wolf, Hans-Heinrich;
    • Einsele, Hermann;
    • Volpert, Sarah;
    • Heinecke, Achim;
    • Berdel, Wolfgang E.;
    • Kienast, Joachim
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21